tag:blogger.com,1999:blog-91848814563246793202024-03-14T02:35:00.442-07:00POWCOR Pancreatic Cancer FundWe are a 501(c)3 organization, raising money for pancreatic cancer research. All money raised is donated to Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center. We hold several events annually to raise money to further research. We began our non-profit organization in hopes of finding a cure for pancreatic cancer. We hope you will join us in the fight against pancreatic cancer.POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.comBlogger10125tag:blogger.com,1999:blog-9184881456324679320.post-2420000699046686432012-02-09T18:20:00.000-08:002012-02-09T18:20:50.241-08:00Welcome 2012It's been quite some time since we've posted on our blog, but we are so excited to announce our upcoming event at the Camden Riversharks Baseball Stadium! The event will take place May 5, 2012! While the date has been set, there is much more information coming your way! We've also received the latest news from the Sidney Kimmel Comprehensive Cancer Center and their most current research and findings. Keep a look out for these updates, our event flyer coming very soon, and tickets being sold on or website for our May 5th event. We would also like to thank those who came out and made our annual golf tournament a huge success. We are incredibly grateful for your support.<br />
<br />
Rebecca and JameyPOWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com1tag:blogger.com,1999:blog-9184881456324679320.post-9613323094058396682011-05-11T17:34:00.000-07:002011-05-15T18:54:47.476-07:00Over the months...Many of you have asked questions about our annual banquet fundraiser we usually have at a bar/restaurant in the Cherry Hill area of NJ this time of year. While it did not happen this year, we want to assure you that Powcor is back in full swing. For those of you that don't know, my (Rebecca's) father passed away this year from pancreatic cancer. As the past months have been difficult, we continue to work toward raising money for Johns Hopkins current research and steps closer toward finding a vaccine for pancreatic cancer.<br /><br /><br />For those of you just coming on to learn about Powcor, we want you to know how passionate we are about this cause. As best friends, we understand each other's sadness and pain that this cancer has brought to both of our families. Perhaps you know someone who is currently battling this awful cancer, you want to honor someone who has passed away, or you simply want to help out a good cause. No matter what the reason, we're so grateful for your support. Some days seem impossible when you have to face coming to terms with what this cancer has done to someone you love. We're not giving up the fight, and we hope you'll support us in winning it.POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-73987155107062555032011-05-11T09:08:00.000-07:002011-05-11T09:09:55.624-07:00Register for the 2nd Annual POWCOR Pancreatic Cancer Fund Golf Outinghttp://events.constantcontact.com/register/event?llr=ybwdmrfab&oeidk=a07e3usr1nn4ba1a8ad<br /><br />Register for the golf outing at the link above or on the main page! Thanks for the support!!POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-59284522872309320752011-05-10T07:02:00.000-07:002011-05-10T07:04:45.026-07:00National Call-In 2011<strong style="color: rgb(153, 51, 153);" class="style3">We need YOU to Call Congress on Tuesday, June 14th</strong> <p align="left"> If you cannot travel to Washington, D.C., to join us for the Fifth Annual Pancreatic Cancer Advocacy Day, we hope that you will participate in the National Call-In. Please mark your calendar for <strong>Tuesday, June 14th</strong> and be prepared to spend 5 minutes placing three very important phone calls that day. <br /><br /> <span style="color: rgb(153, 51, 153);" class="style3">What is the National Call-In?</span> <br /></p><p align="left">The National Call-in is an opportunity for all Pancreatic Cancer Action Network supporters across the country to join together with one voice to tell Congress that while you can't attend Advocacy Day in person, you believe that the time has come for Congress to take action on pancreatic cancer! <br /><br /> <span style="color: rgb(153, 51, 153);" class="style3">How does it work?</span> <br /></p><p align="left">On Monday, June 14th, 2011, you will receive an email with instructions on how to place the calls to your two U.S. Senators and U.S. Representative. The email will include their office phone numbers, and what we'd like for you to say. The calls should take less than 5 minutes of your time, but they will significantly impact our efforts to make the pancreatic cancer community heard. To sign up for the Advocacy E-list (and get e-mails about the National Call-In), <a href="http://capwiz.com/pancan/mlm/verify/" target="_blank">click here</a>. Information about the National Call-In will also be available at <a href="http://www.pancan.org/">www.pancan.org</a> on June 14.<br /><br /> <span style="color: rgb(153, 51, 153);" class="style3">Mark your calendar today!</span><br /></p><p align="left">More than 2,000 phone calls were placed to Congress during the 2010 National Call-In. These calls were a tremendous help in augmenting the in-person meetings that were happening as part of the Advocacy Day. <strong>Please mark your calendar now for the 2011 National Call-In on June 14th and ask your friends and family to do the same.</strong> With your help, we can double the amount of calls that are placed to members of Congress during this year's Advocacy Day and make sure that legislators hear our message loud and clear: Pancreatic Cancer: Know It. Fight It. End It! <br /> <br /><br /> <strong> Questions?</strong> If you have any questions about the Fifth Annual Pancreatic Cancer Advocacy Day, please contact our Government Affairs and Advocacy Department at <a href="mailto:advocacy@pancan.org"><strong>advocacy@pancan.org</strong></a> or <strong>202-742-6699.</strong></p>POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-49025686407677345272010-07-22T07:36:00.000-07:002010-07-22T07:40:01.993-07:00South Jersey Women Making a Difference- For POWCOR Pancreatic Cancer Fund<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqNbKvnDn9SUg0FjNne3EsjCP-AVaPPC5E3XpOroj2QY0lMaTJjG0SyCwhjzV5VZ6cAdAWvMDSIJoUgiglVstAGGATrYHaIgdcsLj6HWye-7oDTCxrty3iivFkQG0c0b4TZhNgpBbp-g4/s1600/IMG_4230.JPG"><img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 222px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqNbKvnDn9SUg0FjNne3EsjCP-AVaPPC5E3XpOroj2QY0lMaTJjG0SyCwhjzV5VZ6cAdAWvMDSIJoUgiglVstAGGATrYHaIgdcsLj6HWye-7oDTCxrty3iivFkQG0c0b4TZhNgpBbp-g4/s320/IMG_4230.JPG" alt="" id="BLOGGER_PHOTO_ID_5496740176629621122" border="0" /></a><br />An up and coming new women's group --- South Jersey Women Making a Difference --- recently informed us about themselves and to let us know that POWCOR had been selected to receive a monetary award.<br /><br />Spokeswoman Deborah Klaszky explained that the group, all professional women from various parts of the state, just formed in January. They meet once a month to not only have fun but also to try, as their name implies, to make a difference by giving back to the South Jersey community.<br /><br />Each member contributes money at the beginning of the evening, then has the opportunity to nominate a person or group she has a personal interest in and who has need for such a contribution. By evening's end, a nominee is chosen to receive the money collected. We were the fortunate recipients this month, and the group invited us to their July meeting to receive the prize, in this case a check for $110.00.<br /><br />We certainly appreciate the thoughtfulness of South Jersey Women Making a Difference in selecting POWCOR and wish all the best for them. Needless to say, their donation will be put to good use in our effort to raise money for pancreatic cancer research!POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-41368270253238319012009-09-25T18:17:00.001-07:002009-09-25T18:32:46.785-07:00Pictures of POWCOR's 1st Roadtrip!<span style="font-family:georgia;">Hello All!<br /><br />As you all know, our 5k walk (and if you want to run, you can!) is coming up on October 31st. Since this is our 1st annual walk, we are working to make it as successful as possible. We began looking for other pancreatic cancer 5k walks, and we found one in Long Island, New York last weekend (9/20/09)! We figured it would be a great if we went to walk for the cure, as well as find great ways to make our 5k a success as well. It ended up being a GREAT experience, and we brought our "entourage" to show the support! From the great DJ to the positive vibes, and the TONS of people walking, we've become more motivated than ever. Please take a look at our pictures and SPREAD the word. We're here to stand up to pancreatic cancer so spread the word about POWCOR - A Cause You Can't Ignore! Thanks to everyone for all of your support to this point. This would not be possible without any of you.</span><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXPAriuu0mz28N7KmIbVkAPJwNwt3sySi1A3jDg-oFCztb0fO6BwNWeT7i-PPuQqwpfgY0cL_gLAMvSx0YEeCfJEMitUBfoiChfz_3BM9twXDOeq42z94ryrprOFDiKRa49TWye7B88Ws/s1600-h/DSCN2220.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXPAriuu0mz28N7KmIbVkAPJwNwt3sySi1A3jDg-oFCztb0fO6BwNWeT7i-PPuQqwpfgY0cL_gLAMvSx0YEeCfJEMitUBfoiChfz_3BM9twXDOeq42z94ryrprOFDiKRa49TWye7B88Ws/s320/DSCN2220.JPG" alt="" id="BLOGGER_PHOTO_ID_5385581266596323154" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNvoBI9bqZyvt6xqjkyXr_4yZUWwA1xI9KkVM92PIy7zVkaWK-NRFW7bjTE-Dj5s8oRKzAwSG3dfKYG7xpIeXxsADNcjwF3jC6pZxUh0tVSoR7QlkSELjsvOtVGmFpIQ05YSP3ol4BfoE/s1600-h/DSCN2228.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNvoBI9bqZyvt6xqjkyXr_4yZUWwA1xI9KkVM92PIy7zVkaWK-NRFW7bjTE-Dj5s8oRKzAwSG3dfKYG7xpIeXxsADNcjwF3jC6pZxUh0tVSoR7QlkSELjsvOtVGmFpIQ05YSP3ol4BfoE/s320/DSCN2228.JPG" alt="" id="BLOGGER_PHOTO_ID_5385581255624392610" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsZI-PAzGcDh65PxajCAUp5BbHSe3SFgKNIID1KwgbMr-K2VpFgN5C9NliNTBftcXXj7YuG9O2Px-ylZGQvSV24kVQ9UUtWsWhqfUGMSYF6m7ekv_k7HplGKYNlt07C4NOr_rxU2KjUyU/s1600-h/DSCN2227.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsZI-PAzGcDh65PxajCAUp5BbHSe3SFgKNIID1KwgbMr-K2VpFgN5C9NliNTBftcXXj7YuG9O2Px-ylZGQvSV24kVQ9UUtWsWhqfUGMSYF6m7ekv_k7HplGKYNlt07C4NOr_rxU2KjUyU/s320/DSCN2227.JPG" alt="" id="BLOGGER_PHOTO_ID_5385581247622318962" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi5gCRKP4OE1VP1pmg3skz0E5XlEaUAeXNa0gEjUzGDqzQFeF65oXZI67MEzmQUAabOTNEkpHaGaN9CGA4MltT1923tZ-kCOa5lF7Zl8PwQeouCQcCtu5K22G21nLupO7vZLZLL2NjLX-s/s1600-h/DSCN2225.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi5gCRKP4OE1VP1pmg3skz0E5XlEaUAeXNa0gEjUzGDqzQFeF65oXZI67MEzmQUAabOTNEkpHaGaN9CGA4MltT1923tZ-kCOa5lF7Zl8PwQeouCQcCtu5K22G21nLupO7vZLZLL2NjLX-s/s320/DSCN2225.JPG" alt="" id="BLOGGER_PHOTO_ID_5385581241729858018" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8Dz9K78GvQUlTkZTZWas6laI_BJDjjmPJAnlumORQDrhxPfLs92R5I_b5AFx1Y5JmrbBqEDVQhC5YOuXRA_nsC2UIySVe_K3YwV_vAHCkoA3RwSKr5I9SYh8jxfo7Za9c5tjL1jUbgTg/s1600-h/DSCN2224.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg8Dz9K78GvQUlTkZTZWas6laI_BJDjjmPJAnlumORQDrhxPfLs92R5I_b5AFx1Y5JmrbBqEDVQhC5YOuXRA_nsC2UIySVe_K3YwV_vAHCkoA3RwSKr5I9SYh8jxfo7Za9c5tjL1jUbgTg/s320/DSCN2224.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580817647245698" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyJdOlAytoWlgYvWhj9sackvtE23Lzv2WS6_EY3NugzgrJ2S4xLUBYAtmVbkea6xeXaybQ1uOa0YkDUooe6zsFN2PChqXqhpBX1PCJuCDE8C6cjxm1_Ufyn-oO5YhKp2PnBEQYl6E5tzY/s1600-h/DSCN2223.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 240px; height: 320px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyJdOlAytoWlgYvWhj9sackvtE23Lzv2WS6_EY3NugzgrJ2S4xLUBYAtmVbkea6xeXaybQ1uOa0YkDUooe6zsFN2PChqXqhpBX1PCJuCDE8C6cjxm1_Ufyn-oO5YhKp2PnBEQYl6E5tzY/s320/DSCN2223.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580808645442898" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg7GS1qfJBlHvtxskM9MwdOZF5lvJUVaC-BteH1BbONVw3W_ngY-qyQj8WiGDnmcAPrMSjFUg1Z-X3_-R7adi-W2PSEh0tFJpoLdLcHywxjYIHySm9mI1hNLeIobMJXwuHnWLYIXSsxf-g/s1600-h/DSCN2222.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg7GS1qfJBlHvtxskM9MwdOZF5lvJUVaC-BteH1BbONVw3W_ngY-qyQj8WiGDnmcAPrMSjFUg1Z-X3_-R7adi-W2PSEh0tFJpoLdLcHywxjYIHySm9mI1hNLeIobMJXwuHnWLYIXSsxf-g/s320/DSCN2222.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580803551840674" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi8PoLwPOSzmPXNM4TyluJfkXLdptW-OURSRI06bDKz1MASbvYOwcW8yyIvM-DopUBIb-9AzdOJVPtk6r2fOfna0PihCYrC1bBWIGDIjqcW8PFa6IfWp-FMqqIrFjm9PWuPBCsD5Z8Z1E4/s1600-h/DSCN2221.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi8PoLwPOSzmPXNM4TyluJfkXLdptW-OURSRI06bDKz1MASbvYOwcW8yyIvM-DopUBIb-9AzdOJVPtk6r2fOfna0PihCYrC1bBWIGDIjqcW8PFa6IfWp-FMqqIrFjm9PWuPBCsD5Z8Z1E4/s320/DSCN2221.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580799047929186" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjtG73FTz5AwjbsVQkwn-61k1rz81-3Fp327ZVcrDyiUVTwHpUo5KPRF3NVzsGGlZ10a8nzGHUUpllz4bBVaC4wLS4y5D6xo3gGoR238OVg-Jbp_RPJ8bBmcp0HbYwdy98cwdqQJyG-x1Q/s1600-h/DSCN2219.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjtG73FTz5AwjbsVQkwn-61k1rz81-3Fp327ZVcrDyiUVTwHpUo5KPRF3NVzsGGlZ10a8nzGHUUpllz4bBVaC4wLS4y5D6xo3gGoR238OVg-Jbp_RPJ8bBmcp0HbYwdy98cwdqQJyG-x1Q/s320/DSCN2219.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580790576155858" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgTUa-lKLI_NfsVO-aqnjRLUriUyvvjFT2AVUGkFM3odyatbvS_nIY7QPC4KEvHqLELl6rF-ehzBvQlVv25Ol-ntZ73ugBz8bxhRt9ntiHrnaP19Al6Qk6rKIR4NyKAFzWw2RSxFreCknU/s1600-h/DSCN2217.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgTUa-lKLI_NfsVO-aqnjRLUriUyvvjFT2AVUGkFM3odyatbvS_nIY7QPC4KEvHqLELl6rF-ehzBvQlVv25Ol-ntZ73ugBz8bxhRt9ntiHrnaP19Al6Qk6rKIR4NyKAFzWw2RSxFreCknU/s320/DSCN2217.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580418394607634" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj31aeD_C_mTAA2A_zEzy5qXd-rNQQuaFObJBODsN3_9PPy46HwF67euS6zBupWB64JQ8QbMJBDQFfu26_hT78BiTskpHkaIAk3jTY3yTj1puqiBlVAXviVhO_B6LED8GbR2RcseHrVN6c/s1600-h/DSCN2216.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj31aeD_C_mTAA2A_zEzy5qXd-rNQQuaFObJBODsN3_9PPy46HwF67euS6zBupWB64JQ8QbMJBDQFfu26_hT78BiTskpHkaIAk3jTY3yTj1puqiBlVAXviVhO_B6LED8GbR2RcseHrVN6c/s320/DSCN2216.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580414698544626" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhb3ATMP6tsdKq9DEcwiJp9hSAoEU3eDWuC_H4Zf_QbqVq32IqHQmj4Nb0uc87mj2w9PshmbXczWgQfVTmcX2LzE-MhaF4RMA3A8ed5zK2tupEa-7GBrTMha2GUsyWU1Xuws1XSmFqdyUM/s1600-h/DSCN2215.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhb3ATMP6tsdKq9DEcwiJp9hSAoEU3eDWuC_H4Zf_QbqVq32IqHQmj4Nb0uc87mj2w9PshmbXczWgQfVTmcX2LzE-MhaF4RMA3A8ed5zK2tupEa-7GBrTMha2GUsyWU1Xuws1XSmFqdyUM/s320/DSCN2215.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580405843745634" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjgD7W1PzlGVVKnjvPrhylKDyaW1HjbC9FzkECvOqQp5pN1PtTTjOh3ECsb1RHOOK0k6_BxqejcReQxUOkRNdzmLZzoKYL5hmEPbxv9pU0O4iaVhwamiO4MZD4riICPE_EgDIGmrYDpxgI/s1600-h/DSCN2214.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjgD7W1PzlGVVKnjvPrhylKDyaW1HjbC9FzkECvOqQp5pN1PtTTjOh3ECsb1RHOOK0k6_BxqejcReQxUOkRNdzmLZzoKYL5hmEPbxv9pU0O4iaVhwamiO4MZD4riICPE_EgDIGmrYDpxgI/s320/DSCN2214.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580402928662866" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi7m9d_yAMu1UFNrqX_bWnwrTJSrWs_QMqsSsSu-lqtSGfqydmNiR2aeQJMGeW0lDlKoX7nRNzf7tOeDyvj-TsHgkmuiEieMUBqsHl4NMEOv2t77HMufrL0EqgtKo3dkHPWryiyn954sr8/s1600-h/DSCN2213.JPG"><img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi7m9d_yAMu1UFNrqX_bWnwrTJSrWs_QMqsSsSu-lqtSGfqydmNiR2aeQJMGeW0lDlKoX7nRNzf7tOeDyvj-TsHgkmuiEieMUBqsHl4NMEOv2t77HMufrL0EqgtKo3dkHPWryiyn954sr8/s320/DSCN2213.JPG" alt="" id="BLOGGER_PHOTO_ID_5385580393211122850" border="0" /></a><span style="font-family:georgia;"></span><input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden"><div id="refHTML"></div><input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden"><div id="refHTML"></div><input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden"><div id="refHTML"></div>POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-49232725198383235762009-09-14T18:38:00.001-07:002009-09-18T14:44:51.199-07:00R.I.P. Patrick Swayze<span class="Apple-style-span" style="color: rgb(51, 51, 51);font-family:Verdana,Arial,Helvetica,sans-serif;font-size:12;" ><p class="tableHeading3" style="font-family: Verdana,Arial,Helvetica,sans-serif; font-size: 12px; font-weight: bold; color: rgb(255, 255, 255); font-style: normal;" align="center">THE PANCREATIC CANCER ACTION NETWORK IS SADDENED BY THE DEATH OF ACTOR PATRICK SWAYZE</p><p style="font-weight: normal; color: rgb(51, 51, 51);font-family:Verdana,Arial,Helvetica,sans-serif;font-size:12px;"><span class="tableHeading4" style="font-weight: bold; color: rgb(255, 255, 255);font-family:Verdana,Arial,Helvetica,sans-serif;font-size:10;" ><strong>EL SEGUNDO, CA – (September 14, 2009) </strong></span><span style="color: rgb(255, 255, 255);">– The Pancreatic Cancer Action Network (www.pancan.org), the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure is mourning the loss of legendary actor Patrick Swayze. His diagnosis shocked fans around the world in early 2008 and his subsequent battle put a spotlight on pancreatic cancer, the fourth leading cause of cancer death in the United States. Swayze is the latest celebrity to succumb to this deadly disease, others before him include: Chuck Daly, Randy Pausch, Luciano Pavarotti, Michael Landon, Donna Reed, Juliet Prowse, Joan Crawford and Jack Benny among others.</span><br /><br /><span style="color: rgb(255, 255, 255);">“On behalf of the Pancreatic Cancer Action Network, I would like to offer my condolences to his wife, Lisa and the entire Swayze family,” said Julie Fleshman, President and CEO. “For nearly two years he was beating the odds stacked against him and his brave, public battle was a beacon of hope for the pancreatic cancer community. The Pancreatic Cancer Action Network will continue to advance research, support patients and create hope in his memory.”</span><br /><br /><span style="color: rgb(255, 255, 255);">Pancreatic cancer is the most lethal cancer in the United States with a five-year survival rate of only 5 percent. This year over 42,000 people will be diagnosed with the disease and over 35,000 will die. Despite the statistics, pancreatic cancer is the most under-funded among leading cancer killers with less than 2 percent of the National Cancer Institute’s annual research budget—a figure far too low given the severity of the disease.</span><br /><br /><span style="color: rgb(255, 255, 255);">In January 2009, the pancreatic cancer community took an important step forward of increased federal research funding for pancreatic cancer by developing the first-ever substantive pancreatic cancer legislation introduced in the U.S. Congress. The </span><em style="color: rgb(255, 255, 255);">Pancreatic Cancer Research and Education Act</em><span style="color: rgb(255, 255, 255);"> (H.R. 745), which was introduced by U.S. Representatives Anna Eshoo (D-CA) and Ginny Brown-Waite (R-FL), proposes comprehensive research initiatives and programs that would facilitate finding a cure for pancreatic cancer. Once enacted and fully funded, this legislation will create a more targeted approach to fighting pancreatic cancer and provide scientists with the resources necessary to make significant advances.</span><br /><br /><span style="color: rgb(255, 255, 255);">To learn more about the Pancreatic Cancer Action Network, visit www.pancan.org.</span><br /></p></span><input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden"><div id="refHTML"></div>POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-23341906074711936132009-09-14T06:04:00.001-07:002009-09-14T06:07:19.816-07:00POWCOR 5K Walk- Register Now!!<img src="webkit-fake-url://7A23CB80-363A-43D1-8D1A-BB587044E997/image.tiff" />POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com1tag:blogger.com,1999:blog-9184881456324679320.post-55535218378622911432009-09-11T16:54:00.000-07:002009-09-11T18:01:00.593-07:00Comprehensive Genetic Blueprints Revealed For Lethal Pancreatic, Brain CancersThe complete genetic blueprint for lethal pancreatic cancer and brain cancer was deciphered by a team at the Johns Hopkins Kimmel Cancer Center. <div><br /></div><div>The studies, led by the same group who completed maps of the breast cancer and colorectal cancer genomes in 2007, are reported in two articles in the Sept. 5, 2008, issue of Science Express.</div><div><br /></div><div>Believed to be the most comprehensive result to date for any tumor type, the new map evaluated mutations in virtually all known human protein-encoding genes, comprised of more than 20,000 genes, in 24 pancreatic cancers and 22 brain cancers. </div><div><br /></div><div>A core set of regulatory gene processes and pathways, about a dozen for each tumor type, were found to be altered in the majority of tumors studied by the researchers. In pancreatic cancer, these 12 pathways, including those linked to DNA damage control, cell maturation, and tumor invasion, were altered in 67 percent to 100 percent of tumors. </div><div><br /></div><div>"This perspective changes the way we think about solid tumors and their management, because drugs or other agents that target the physiologic effects of these pathways, rather than individual gene components, are likely to be the most useful approach for developing new therapies," says Bert Volgelstein, M.D., co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator. In addition to the pathway discoveries, a number of individual mutated genes were identified, including 83 cancer genes in pancreatic cancer and 42 in the most lethal form of brain cancer, glioblastoma multiforme (GBM), Additionally, 70 genes that were dramatically overexpressed in either cancer encode proteins that are on the surface of cells or secreted, making them potential diagnostic and screening targets. </div><div><br /></div><div>One gene, isocitrate dehydrogenase 1 (IDH1), was found to be frequently mutated in a subset of GBM brain cancers. The mutations were significantly more common in young GBM patients, and were associated with improved survival. IDH1 mutations were also found in nearly all cases of secondary GBMs (cancers that progress from pre-existing lower grade tumors), raising the possibility that this mutation may be a useful marker for identifying which low grade brain tumors are most likely to develop into the lethal GBMs.</div><div><br /></div><div>"Patients with IDH1 mutations seem to be different from other patients with GBM, both clinically and biologically," says Victor Velculescu, M.D., Ph.D., associate professor of oncology. "It is conceivable that these patients will ultimately benefit from different treatments, potentially by targeting IDH1." </div><div><br /></div><div>"The landscape of human cancers is clearly more complex that has been previously appreciated. Fighting it is going to be more of a guerilla war than a conventional one because there are dozens of mutated genes in each tumor," says Kenneth W. Kinzler, Ph.D., co-director of the Ludwig Center at Johns Hopkins and professor of oncology. "Individually, these mutations don't seem formidable. But working together, they form an enemy that will require us to develop novel strategies to combat them, and the best long-term strategy may be early detection of tumors, when the number of guerilla warriors is still small and more easily handled." </div><div><br /></div><div>To make their findings, the investigators integrated several methods of genetic analysis. They used high-density microarrays to identify copy number alterations (amplifications and deletions) and next-generation sequencing technologies to evaluate gene expression. They also develop novel statistical algorithms to integrate these complementary genetic analyses, as well as techniques to separate alterations likely to contribute to cancer initiation and progression from so-called passenger mutations, which accumulate harmlessly during cancer development. </div><div><br /></div><div>Each project cost more than $4 million, with lead funding for the Goldman Pancreatic Cancer Genome Initiative coming from the Sol Goldman Charitable Trust. The Virginia and D. K. Ludwig Foundation provided lead funding for the brain cancer project. The Ludwig Brain Tumor Initiative represents the first formal collaboration of Ludwig Centers established by the Ludwig Fund in 2006. </div><div><br /></div><div>This year an estimated 38,000 people will develop pancreatic cancer in the United States, with overall survival rates less than 5 percent. Although fewer patients are diagnosed with brain cancers (approximately 20,000 cases per year in the United States), the results are equally catastrophic. "The main reasons we chose to focus on these cancers is because they are so deadly and have such limited treatment options. What we learn about these tumors may lead to improved diagnostic measures or therapies in the future," says Ralph Hruban, M.D., director of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins. </div><div><br /></div><div>The Lustgarten Foundation provided significant funding for the pancreatic cancer research. Additional funding came from the Virginia and D.K. Ludwig Fund, Susan G. Komen Foundation, Michael Rolfe Pancreatic Cancer Foundation, Joseph C. Monastra Foundation, the family and friends of George Rubis, Viragh Family Foundation, Broad Foundation, Emerald Foundation, and National Institutes of health. </div><div><br /></div><div><br /></div>POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0tag:blogger.com,1999:blog-9184881456324679320.post-46843220872794267312009-09-10T08:37:00.000-07:002009-09-10T09:41:22.326-07:00TV Industry Foundation Picks Hopkins Scientists For Cancer Research "Dream Teams""Stand Up To Cancer" research funds raised by ABC, CBS, NBC telecast last fall.<div><br /></div><div>A TV industry- and celebrity-driven cancer research project has chosen scientists at Johns Hopkins for two of five multi-institutional "dream teams" financed by "Stand Up To Cancer" grants totaling more than $6 million. </div><div><br /></div><div>The grants, established by the Entertainment Industry Foundation, are funded with $73.6 million raised during a simultaneous, primetime, television broadcast on ABC, CBS, and NBC television networks last September. </div><div><br /></div><div>Two awards to Johns Hopkins- led teams were chosen by a 20-member panel of scientists, physicians and patient advocates who reviewed 237 applications. </div><div><br /></div><div>The Johns Hopkins research will focus on pancreatic cancer and epigenetics, a relatively new field of research directed at understanding and manipulating gene alterations that can shut down natural cancer protection. </div><div><br /></div><div>Stephen Baylin, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer at Johns Hopkins, will co-lead with Peter A. Jones, Ph.D., D.Sc., director of the University of Southern California/Norris Comprehensive Cancer Center a $9.12 million, three-year grant to study epigenetic changes that modify the way a cell packages its DNA sequence for regulating gene function. Abnormal DNA packaging silences genes that confer cancer protection in people with lung, breast and colon cancers. The Johns Hopkins-USC-led Dream Team will conduct legal trials and laboratory investigations to test potential treatments to reverse this silencing of genes. </div><div><br /></div><div>"We will be looking for signatures in the genomes of tumor cells from patients with leukemia, lung, breast and colon cancer that can predict whether cancers in certain patients are susceptible to these therapies," says Baylin, who is the Virginia & D.K. Ludwig Professor in Cancer Research. "Tracking the signatures can also help monitor patients' response to the drug."</div><div><br /></div><div>Johns Hopkins scientists will receive approximately $3 million for its portion of the epigenetics grant. Other institutions in the epigenetics dream team are the University of Pittsburgh, the University of Texas MD Anderson Cancer Center, and the Lovelace Respiratory Research Institute at the University of New Mexico. Johns Hopkins team members are: Nita Ahuja, M.D., Nilofer Azad, M.D., Malcolm Brock, M.D., Robert Casero, Jr., Ph.D., Leslie Cope, Ph.D., Edward Gabrielson, M.D., James Herman, M.D., Rosalyn Juergens, M.D., William Matsui, M.D., Charles Rudin, M.D., Ph.D., Vared Stearns, M.D., Jeff Wang, Ph.D., and Cynthia Zahnow, Ph.D. </div><div><br /></div><div>For pancreatic cancer research, scientists at Johns Hopkins will be awarded $3.75 million in Stand Up to Cancer grants, plus clinical trial funding from the $18 million grant led by Craig Thompson, M.D., director of the Abramson Cancer Center at the University of Pennsylvania and Daniel Von Hoff. M.D., physician-in-chief and director of the Clinical Translational Research Division at the Translational Genomics Research Institute (TGen) and Chief Scientific Officer at Scottsdale Healthcare. </div><div><br /></div><div>Johns Hopkins investigators will use their funds to test and develop drugs that target faulty enzymes that process glutamine and glucose and fatty acids in some pancreatic cancers. "There are some drugs already approved for diabetic management that have evidence of antitumor effects," says Chi Dang, M.D., Ph.D., vice dean for research at the Johns Hopkins University School of Medicine and advisor for the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins. "These drugs could be combined with other therapies currently being tested for pancreatic cancer."</div><div><br /></div><div>In addition to Dang, the pancreatic cancer research team includes Manuel Hidalgo, M.D., Ph.D., Ralph Hruban, M.D., Kenneth Kinzler, Ph.D., Daniel Laheru, M.D., Anirban Maitra, M.D., Martin Pomper, M.D., Ph.D., and Victor Velculescu, M.D., Ph.D., from the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins, and David L. Vander Jagt, Ph.D. of the University of New Mexico. </div><div><br /></div><div>Velculescu and Kinzler at Johns Hopkins will scan patients' genomes for genes that could benefit from glutamine and glucose-blocking drugs. Hidalgo and Maitra plan to track drug response. "We also will be looking for experimental drugs, not currently FDA-approved, which could have the same blocking effect on glucose and glutamine metabolism," says Dang, professor of medicine, cell biology, oncology and pathology. </div><div><br /></div><div>On the web:</div><div>videos of Baylin and Dang available at: www.hopkinskimmelcancercenter.org</div><div>SU2C press kit: www.su2c.org</div><div><br /></div>POWCOR Pancreatic Cancer Fundhttp://www.blogger.com/profile/13063897338348830646noreply@blogger.com0